Although most of our children were using ART/cART at lymphoma diagnosis, they did not start treatment with cART as the first antiretroviral therapy but with suboptimal treatments, which could explain the low cohort CD4+ T-cell counts at lymphoma diagnosis. This evidence concerns the gene CD4 and lymphoma.